Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Match Group Q3 Adj. EBITDA $285M, Sales $802.00M Miss $802.09M Estimate

Match Group (NASDAQ:MTCH) reported quarterly sales of $802.00 million which missed the analyst consensus estimate of $802.09 million by 0.01 percent. This is a 25.36 percent increase over sales of $639.77 million the
byBenzinga Newsdesk
November 2, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Match Group (NASDAQ:MTCH) reported quarterly sales of $802.00 million which missed the analyst consensus estimate of $802.09 million by 0.01 percent. This is a 25.36 percent increase over sales of $639.77 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For Cytek Biosciences

By Benzinga Insights
November 8, 11:26 AM
Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Cytek Biosciences will report an earnings per share (EPS) of $0.02.

CTKB